The relentless selling by FIIs continued in November. After selling...
Category:
Indian News
Latest
Cost and debt rising, yield stagnant: SC panel on agri distress; suggests examining MPS, other measures
The panel also said climate catastrophe and the resulting severity...
TN sets up ‘One Health and Climate Hub’ to address health challenges of climate change
A government order (GO) issued by Additional Chief Secretary...
India reports 41,383 new COVID-19 cases, deaths rise by 507
India’s daily positivity rate remained less than 3 per cent for 31 consecutive days. The positivity rate stood at 2.41 per cent.
Rs 500-cr COVID claims leave ICICI Prudential in the red with Rs 186 cr Q1 net loss
On the massive pandemic claims, Kannan said the company had a gross claim of Rs 1,100 crore from 5,000 insured, which translates into Rs 500 crore net claims (as the remainder of the claims is paid by the reinsurers). This is 2.5X of what it settled in the whole of last year — net paid only Rs 200 crore to 2,000 people. Kannan further said all of the Rs 500-crore net claim is not paid yet but refused to share the exact settled amount, saying as a policy they set aside funds for the entire claims filed for.
Tax reduction, pandemic-driven cost cuts buoys India Inc net by 105% in FY21: Report
The tax cut has contributed 19 per cent to the topline of these companies during the pandemic with cement, tyre and consumer durables gaining in excess of 50 per cent, it added.
More importantly, 15 sectors led by refineries, steel, fertilisers, textiles, pharma, IT, mining, etc reduced their loan funds in the range of 6-64 per cent or to the tune of Rs 2.09 lakh crore in FY21, which again boosted their bottomline.
Over 150 children found COVID-positive as Mizoram reports highest daily cases
Hospitals have become large industries, thrive on human distress: SC
“Hospitals have become a large industry now based on human distress. We cannot allow them to prosper at the cost of human lives. Let such hospitals be closed and allow the state to bolster health care facilities. Let not such hospitals operate in buildings with four rooms etc.,” said Justice Chandrachud while noting that a number of hospitals don’t adhere to fire safety norms.
4 Covid vaccine candidates in human trial stage, 1 in pre-clinical stage: Govt
Currently, three vaccines — Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Russian vaccine Sputnik V — are being administered in India.
US eases travel recommendations on India as COVID-19 cases fall
The improvement of the travel advisories for India and Pakistan by the State Department on Monday comes in an acknowledgment of the improving COVID-19 pandemic situation in the region.
Over 45,000 cases of mucormycosis reported in India: Health ministry tells Rajya Sabha
Mucormycosis and other fungal infections are most commonly seen as an opportunistic infection. They are found in those with low underlying immunity either due to a diabetes, cancers particularly hematological malignancies, etc. or as a side effect of prolonged/irrational use of certain drugs like steroids, immunosuppressive drugs for management of other disorders including Covid-19, the minister explained.
Allow life insurers to sell pension-based health policies: HDFC Life Chairman
”Across the world, both pension and health cover are very much part of life insurance, as they protect people from longevity and morbidity risks.Hence, allowing life insurers to distribute products such as health indemnity, NPS would help improve the much-needed insurance reach across the country,” he said.
48.68 crore Covid vaccine doses manufactured in India: Govt
Under the ”Mission COVID Suraksha, facility augmentation for production of Covaxin is being supported, whereby Bharat Biotech and three public sector enterprises (PSEs) — Haffkine Biopharmaceutical Corporation Limited in Mumbai, Indian Immunologicals Limited (IIL) in Hyderabad and Bharat Immunologicals Biologicals Limited (BIBCOL) in Bulandshahr — are being supported.